Effect of tamsulosin versus prazosin on clinical and urodynamic parameters in women with voiding difficulty: A randomized clinical trial

International Journal of General Medicine

Volumn 4, Issue , 2011, Pages 35-39

  Hajebrahimi, Sakineh ^a   Asrbadr, Yadollah Ahmadi ^a   Azaripour, Arash ^a   Sadeghi Bazargani, Homayoun ^b,c  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Prazosin; Tamsulosin; Voiding dysfunction

Indexed keywords

PRAZOSIN; TAMSULOSIN;

ADULT; AGED; ARTICLE; BLADDER NECK STENOSIS; BLURRED VISION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DROWSINESS; DRUG EFFECT; DRUG EFFICACY; DRUG PREFERENCE; DRUG TOLERABILITY; FEMALE; HEADACHE; HUMAN; ORTHOSTATIC HYPOTENSION; OUTCOME ASSESSMENT; PALLIATIVE THERAPY; PATIENT ASSESSMENT; PATIENT COMPLIANCE; PATIENT SATISFACTION; PRESCRIPTION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; TREATMENT DURATION; URODYNAMICS;

EID: 84897365076     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/IJGM.S16063     Document Type: Article

References (16)

1. Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub- committee of the International Continence Society. Neurourol Urodyn. 2002;21:167-178.
2. Roehrborn CG. The assessment of patient complaints. Prog Clin Biol Res. 1994;386:73-96.
3. Hajebrahimi S, Madaen SK. Prevalence of urinary incontinence in Tabrizian women. Iranian J Urol. 2001:61-64.
4. Groutz A, Blaivas JG. Non-neurogenic female voiding dysfunction. Curr Opin Urol. 2002;12:311-316.
5. Kakizaki H, Ameda K, Kobayashi S, Tanaka H, Shibata T, Koyanagi T. Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder. Int J Urol. 2003;10:576-581.
6. Lee KS, Han DH, Lee YS, et al. Efficacy and safety of tamsulosin for the treatment of non-neurogenic voiding dysfunction in females: a 8-week prospective study. J Korean Med Sci. 2010;25:117-122.
7. Pischedda A, Pirozzi FF, Madonia M, Cimino S, Morgia G. Use of alpha1-blockers in female functional bladder neck obstruction. Urol Int. 2005;74:256-261.
8. Sivkov AV, Romikh VV, Egorov AA. Use of alpha1-adrenergic blockaders in voiding disorders in women. Urologiia. 2002:52-63.
9. Hajebrahimi S, Azaripour A, Sadeghi-Bazargani H. Clinical and transperineal ultrasound findings in females with stress urinary incontinence versus normal controls. Pakistan J Biol Sci. 2009;12(21): 1434-1437.
10. Hajebrahimi S, Azaripour A, Sadeghi-Bazargani H. Tolterodine immediate release improves sexual function in women with overactive bladder. J Sex Med. 2008;5(12):2880-2885.
11. Clarke B. The role of urodynamic assessment in the diagnosis of lower urinary tract disorders. Int Urogynecol J Pelvic Floor Dysfunct. 1997; 8:196-199.
12. Massey JA, Abrams PH. Obstructed voiding in the female. Br J Urol. 1988;61:36-39.
13. Rossi C, Kortmann BB, Sonke GS, et al. Alpha-blockade improves symptoms suggestive of bladder outlet obstruction but fails to relieve it. J Urol. 2001;165:38-41.
14. Whitfield H, Hendry W. Textbook of genito-urinary surgery. 7th ed. Edinburgh: Churchill Livingstone; 1985.
15. Abrams P, Speakman M, Stott M, Arkell D, Pocock R. A dose-ranging study of the efficacy and safety of tamsulosin, the first prostate-selective alpha-1A-adrenoceptor antagonist, in patients with benign prostatic obstruction (symptomatic benign prostatic hyperplasia). Br J Urol. 1997;80:587-596.
16. Gu B, Reiter JP, Schwinn DA, et al. Effects of alpha-1-adrenergic receptor subtype selective antagonists on lower urinary tract function in rats with bladder outlet obstruction. J Urol. 2004;172:758-762.